SCHEMBL2477252

SCHEMBL2477252

COc1ccc(NC(=O)N(CCCN2CCOCC2)Cc2ccc(C(=O)Nc3ccccc3N)cc2)cc1OC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.64
HDAC1 Q13547 4/20 0.56
HDAC2 Q92769 2/20 0.55
ALDH1A1 P00352 5/20 0.52
KDM4E B2RXH2 3/20 0.52
LMNA P02545 3/20 0.52
MAPT P10636 3/20 0.51
POLB P06746 1/20 0.51
GAA P10253 1/20 0.51
HDAC3 O15379 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HSD17B10 Q99714 3/20 0.48
HPGD P15428 2/20 0.48
ROCK2 O75116 1/20 0.48
MAPK1 P28482 1/20 0.48
OPRM1 P35372 1/20 0.48
OPRD1 P41143 1/20 0.48
MEN1 O00255 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2476477 0.90 USP2 (0.54) TSHRHDAC1HDAC2ALDH1A1KDM4E
SCHEMBL2477705 0.90 HDAC1 (0.57) TSHRHDAC1HDAC2ALDH1A1KDM4E
SCHEMBL2473883 0.90 TSHR (0.57) TSHRHDAC1ALDH1A1LMNAMAPT
SCHEMBL2476317 0.89 TSHR (0.53) TSHRHDAC1ALDH1A1KDM4ELMNA
SCHEMBL2478739 0.89 OPRM1 (0.55) TSHRHDAC1HDAC2MAPTHDAC3
SCHEMBL2473939 0.88 TSHR (0.60) TSHRHDAC1ALDH1A1KDM4ELMNA
SCHEMBL4224529 0.88 TSHR (0.60) TSHRHDAC1HDAC2ALDH1A1KDM4E
SCHEMBL2476586 0.88 HSD17B10 (0.55) TSHRHDAC1HDAC2ALDH1A1KDM4E
SCHEMBL2477106 0.88 OPRM1 (0.54) TSHRHDAC1HDAC2ALDH1A1KDM4E
SCHEMBL2475852 0.88 OPRM1 (0.53) TSHRHDAC1HDAC2MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8076332-B2 N- (2-aminophenyl) benzamide derivative having urea structure SANTEN PHARMACEUTICAL CO., LTD. (JP) 2011-12-13 US disclosed
US-8076332-B2 N- (2-aminophenyl) benzamide derivative having urea structure SANTEN PHARMACEUTICAL CO., LTD. (JP) 2011-12-13 US disclosed
US-8076332-B2 N- (2-aminophenyl) benzamide derivative having urea structure SANTEN PHARMACEUTICAL CO., LTD. (JP) 2011-12-13 US disclosed
EP-2107052-B1 NOVEL N-(2-AMINOPHENYL)BENZAMIDE DERIVATIVE HAVING AN UREA STRUCTURE SANTEN PHARMACEUTICAL CO LTD (JP) 2011-10-12 EP disclosed
US-20090306077-A1 NOVEL N- (2-AMINOPHENYL) BENZAMIDE DERIVATIVE HAVING UREA STRUCTURE SANTEN PHARMACEUTICAL CO., LTD. (JP) 2009-12-10 US disclosed
US-20090306077-A1 NOVEL N- (2-AMINOPHENYL) BENZAMIDE DERIVATIVE HAVING UREA STRUCTURE SANTEN PHARMACEUTICAL CO., LTD. (JP) 2009-12-10 US disclosed
US-20090306077-A1 NOVEL N- (2-AMINOPHENYL) BENZAMIDE DERIVATIVE HAVING UREA STRUCTURE SANTEN PHARMACEUTICAL CO., LTD. (JP) 2009-12-10 US disclosed
EP-2107052-A1 NOVEL N-(2-AMINOPHENYL)BENZAMIDE DERIVATIVE HAVING AN UREA STRUCTURE Santen Pharmaceutical Co., Ltd (JP) 2009-10-07 EP disclosed
EP-2107052-A1 NOVEL N-(2-AMINOPHENYL)BENZAMIDE DERIVATIVE HAVING AN UREA STRUCTURE Santen Pharmaceutical Co., Ltd (JP) 2009-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306077-A1 NOVEL N- (2-AMINOPHENYL) BENZAMIDE DERIVATIVE HAVING UREA STRUCTURE UACA, SLC14A1, ARG2 TSHR 2476/4885HDAC1 200/4885HDAC2 129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.